Amalgamated Bank Sells 437 Shares of Humana Inc. $HUM

Amalgamated Bank trimmed its position in shares of Humana Inc. (NYSE:HUM) by 1.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,317 shares of the insurance provider’s stock after selling 437 shares during the quarter. Amalgamated Bank’s holdings in Humana were worth $5,701,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Cary Street Partners Investment Advisory LLC boosted its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares in the last quarter. Zions Bancorporation National Association UT bought a new stake in Humana in the 1st quarter valued at $37,000. CVA Family Office LLC lifted its position in Humana by 63.4% in the 2nd quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after acquiring an additional 85 shares in the last quarter. Ransom Advisory Ltd bought a new stake in Humana in the 1st quarter valued at $66,000. Finally, Transamerica Financial Advisors LLC lifted its position in Humana by 1,027.6% in the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after acquiring an additional 298 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Saturday, August 2nd. Bank of America lifted their price target on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. The Goldman Sachs Group began coverage on shares of Humana in a research note on Tuesday, October 14th. They issued a “sell” rating and a $235.00 price target on the stock. Finally, Morgan Stanley lowered their price target on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $297.58.

Humana Stock Down 2.7%

Humana stock opened at $278.02 on Friday. The firm has a market capitalization of $33.44 billion, a PE ratio of 21.34, a P/E/G ratio of 1.71 and a beta of 0.42. The company’s 50-day moving average is $281.34 and its 200-day moving average is $258.81. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $315.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.96 earnings per share. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, December 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s payout ratio is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.